1H-Indole-5-ethanesulfonamide, N-methyl-3-(1-methyl-4-piperidinyl)-, hydrochloride (1:1)
-
1H-Indole-5-ethanesulfonamide, N-methyl-3-(1-methyl-4-piperidinyl)-, hydrochloride (1:1)
structure -
-
CAS No:
143388-64-1
-
Formula:
C17H25N3O2S.ClH
-
Chemical Name:
1H-Indole-5-ethanesulfonamide, N-methyl-3-(1-methyl-4-piperidinyl)-, hydrochloride (1:1)
-
Synonyms:
1H-Indole-5-ethanesulfonamide,N-methyl-3-(1-methyl-4-piperidinyl)-,hydrochloride (1:1);1H-Indole-5-ethanesulfonamide,N-methyl-3-(1-methyl-4-piperidinyl)-,monohydrochloride;GR 85548A;Naratriptan hydrochloride;Amerge;Naramig;N-Methyl-3-(1-methyl-4-piperidinyl)-1H-indole-5-ethanesulfonamide hydrochloride;Naratrex 1
- Categories:
-
CAS No:
Description
Naratriptan hydrochloride is a selective 5-HT1 receptor subtype agonist and is a triptan drug that is used for the treatment of migraine headaches.Target: 5-HT1 ReceptorNaratriptan is a triptan drug marketed by GlaxoSmithKline and is used for the treatment of migraine headaches. Naratriptan is available in 2.5 mg tablets. It is a selective 5-HT1 receptor subtype agonist. Naratriptan is used for the treatment of the acute migraine attacks and the symptoms of migraine, including severe, th
Naratriptan Hydrochloride is the hydrochloride salt form of naratriptan, a sulfonamide with selective serotonin (5-HT) 1 receptor agonistic activity and anti-migraine property. Naratriptan hydrochloride binds selectively and with high affinity to the 5-HT1D and 5-HT1B receptor subtypes. Activation of these 5-HT1D/B receptors located on intracranial blood vessels leads to vasoconstriction and provides relief of migraine headaches. Naratriptan hydrochloride may also exerts its effect by stimulation of 5-HT1D/1B receptors on sensory nerve endings in the trigeminal system thereby decreasing the release of pro-inflammatory neuropeptides.
1H-Indole-5-ethanesulfonamide, N-methyl-3-(1-methyl-4-piperidinyl)-, hydrochloride (1:1) Basic Attributes
371.93
371.143433
10X8X4P12Z
DTXSID6049064
C47633
Characteristics
73.6
4.28040
white to off-white
234-236°C
541.3°C at 760 mmHg
281.2ºC
H2O: ≥10mg/mL
-20°C Freezer
8.81E-12mmHg at 25°C
Safety Information
NONH for all modes of transport
36
26
Xi
P305 + P351 + P338
H319
|Warning|H319 (98.45%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]|P264, P280, P305+P351+P338, and P337+P313|Aggregated GHS information provided by 129 companies from 3 notifications to the ECHA C&L Inventory.
Drug Information
Drugs used to cause constriction of the blood vessels. (See all compounds classified as Vasoconstrictor Agents.)|Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT1 RECEPTORS. Included under this heading are agonists for one or more of the specific 5-HT1 receptor subtypes. (See all compounds classified as Serotonin 5-HT1 Receptor Agonists.)
1H-indole-5-ethanesulfonamide, N-methyl-3-(1-methyl-4-piperidinyl)-, monohydrochloride
1H-Indole-5-ethanesulfonamide, N-methyl-3-(1-methyl-4-piperidinyl)-, hydrochloride (1:1) Use and Manufacturing
Preparation of Naratriptan hydrochloride (I) :-; The compound (VIII) (50 g, 1501 mmol) was dissolved in mixture of methanol: acetic acid (0.2 lit:0.2 lit) and 2.5 g platinum oxide was added. The mixture was hydrogenated using 5kg/cmPreparation of naratriptan hydrochloride; Naratriptan (50g, 0.14mol) was dissolved in ethanol (500ml).The clear solution was acidified with ethanolic-hydrochloride to a pη of 1.0-1.5 at 25-30°C under nitrogen atmosphere. The reaction mass was further stirred for 60 minutes at 0-5°C, filtered, washed with ethanol and dried to obtain 52.5g of naratriptan hydrochloride ( yield 95.4percent) having purity of 99.77percent by ηPLC. Naratriptan (50g) was dissolved in a mixture of methanol and ethanol (1:9) at 600C till clear solution was obtained. Thereafter, pH of the reaction mixture was adjusted to 1.0 with ethanolic hydrogen chloride at 25C. The reaction mixture was cooled to 5 0C and stirred for 1 hour at same temperature. The solid thus precipitated was filtered and recrystallized from water (300ml). The resulting product was filtered, washed with ethanol to 80.8g (71.7percent) of the tile compound having purity 99.95percent by HPLC.
laxative
Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients
Computed Properties
Molecular Weight:371.9
Hydrogen Bond Donor Count:3
Hydrogen Bond Acceptor Count:4
Rotatable Bond Count:5
Exact Mass:371.1434259
Monoisotopic Mass:371.1434259
Topological Polar Surface Area:73.6
Heavy Atom Count:24
Complexity:483
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes
Recommended Suppliers of 1H-Indole-5-ethanesulfonamide, N-methyl-3-(1-methyl-4-piperidinyl)-, hydrochloride (1:1)
-
CN
5 YRS
Business licensedTrader Supplier of Intermediates,Building blocks,API,Silicones,Peptides,Lab chemicals,Biochemicals,Pharmaceuticals,Screening Compounds,Food Additives -
CN
5 YRS
Business licensedTrader Supplier of PVC resin,pvc paste resin,melamineInquiryCAS No.: 143388-64-1Grade: Industrial GradeContent: 99%
Latest News on 1H-Indole-5-ethanesulfonamide, N-methyl-3-(1-methyl-4-piperidinyl)-, hydrochloride (1:1)
- BMS Over $900 Million to Help Develop Potential 'Best-in-class' SHP2 Inhibitors
- AbbVie's blockbuster product for atopic dermatitis, Upadacitinib, has been approved for marketing in the EU and Japan
- Designing peptide inhibitors for possible COVID-19 treatments
- Chinese scientists discover the inhibitors of SARS-CoV-2
Learn More Other Chemicals
-
Dabrafenib
1195765-45-7
-
BOC-VAL-VAL-OH
69209-73-0
-
BMS 303141
943962-47-8
-
(2S)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylsulfanylbutanamide Formula
60117-17-1
-
(2S)-2-acetamido-6-amino-N-[(2S)-2-amino-3-methylbutanoyl]-N-propylhexanamide Formula
57899-96-4
-
1-(6-methoxy-1,3-benzothiazol-2-yl)-3-phenylurea Formula
26130-02-9
-
L-Tyrosyl-L-phenylalanine Structure
17355-11-2
-
C-REACTIVE PROTEIN FRAGMENT 77-82 Structure
130349-01-8
-
What is Sildenafil
139755-83-2
-
What is Dacomitinib
1110813-31-4
1H-Indole-5-ethanesulfonamide, N-methyl-3-(1-methyl-4-piperidinyl)-, hydrochloride (1:1)
SDSRequest for Quotation